HDAC6 and breast carcinoma: The inhibition of HDAC6 in triple-negative breast cancer cells showed reduced levels of glycolytic metabolites such as PEP, 3-phosphoglyceric acid (3PG), lactate, and pyruvate [198], confirming the involvement of HDAC6 in regulating glycolysis in breast cancer cells.